{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T10:48:45Z","timestamp":1784198925400,"version":"3.55.0"},"reference-count":37,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T00:00:00Z","timestamp":1748995200000},"content-version":"vor","delay-in-days":3,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["J cachexia sarcopenia muscle"],"published-print":{"date-parts":[[2025,6]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Sarcopenia is defined as the loss of muscle mass, strength, and\/or performance. It is strongly associated with all\u2010cause mortality. Fibroblast growth factor 23 (FGF23) is markedly elevated in patients with chronic kidney disease, especially those receiving maintenance dialysis. FGF23 has previously been shown to have a direct role in cardiac dysfunction mediated through left ventricular hypertrophy. However, its role in the development of (or protection from) sarcopenia is uncertain. This study is aimed at determining the relationship between FGF23 and muscle\u2010related parameters and to assess the effect of FGF23 on skeletal muscle myoblasts.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A single centre, cross\u2010sectional study examining maintenance haemodialysis patients was conducted. Sarcopenia was defined in accordance with the revised European Working Group on Sarcopenia in Older People and the Asian Working Group for Sarcopenia criteria. Clinical assessment methods included bioelectrical impedance analysis, anthropometric measurement, handgrip strength and physical performance appraisal. Both intact FGF23, which is biologically active, and the inactive C\u2010terminal FGF23 were measured using enzyme\u2010linked immunosorbent assays. The direct effects of FGF23 on skeletal muscle myoblast proliferation and myogenic differentiation were assessed using an in\u00a0vitro culture system. Linear and logistic regression analyses were performed to examine the associations between FGF23 and muscle\u2010related parameters and sarcopenia, respectively.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Eighty\u2010one patients were included with a median age of 75 years (interquartile range 67\u201380), and 63% were male. Log\u2010transformed serum FGF23 correlated positively with handgrip strength (<jats:italic>r<\/jats:italic>\u2009=\u20090.27, <jats:italic>p<\/jats:italic>\u2009=\u20090.01, 95% confidence interval (CI) 0.06\u20130.46) and calf circumference (<jats:italic>r<\/jats:italic>\u2009=\u20090.27, <jats:italic>p<\/jats:italic>\u2009=\u20090.01, 95% CI 0.06\u20130.46), and in multiple regression analyses, it was found to be a significant independent predictor of both handgrip strength (beta\u2009=\u20095.39, 95% CI 2.07\u20138.72) and sarcopenia (odds ratio\u2009=\u20090.14, 95% CI 0.02\u20130.75). FGF23 was found to promote myoblast proliferation but attenuate myogenic differentiation. At 48\u2009h of differentiation, the expressions of <jats:italic>MyoG<\/jats:italic> and <jats:italic>MyoD<\/jats:italic> were significantly lower in cells treated with FGF23 than the control. The fusion index and myotube diameters were reduced on Day 7 of differentiation in FGF23\u2010treated cells compared to the control.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Higher serum FGF23 levels were associated with stronger handgrip strength and lower odds of having sarcopenia in maintenance haemodialysis patients. Our findings suggest that supraphysiological levels of FGF23 might play a role in muscle regeneration by promoting myoblast proliferation but repressing myogenic differentiation to support the expansion of the proliferative pool. FGF23 could potentially serve as a serum biomarker for muscle health in dialysis populations.<\/jats:p><\/jats:sec>","DOI":"10.1002\/jcsm.13848","type":"journal-article","created":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T09:42:36Z","timestamp":1749030156000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Fibroblast Growth Factor 23 and Sarcopenia in Maintenance Haemodialysis Population"],"prefix":"10.1002","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0604-0380","authenticated-orcid":false,"given":"Limy","family":"Wong","sequence":"first","affiliation":[{"name":"Department of Renal Medicine Monash University Eastern Health Clinical School  Victoria Australia"},{"name":"Department of Renal Medicine Eastern Health  Victoria Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Kenny","sequence":"additional","affiliation":[{"name":"Department of Renal Medicine Monash University Eastern Health Clinical School  Victoria Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny\u00a0Y.\u00a0Y.","family":"Ooi","sequence":"additional","affiliation":[{"name":"Department of Renal Medicine Monash University Eastern Health Clinical School  Victoria Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yung\u00a0Shing","family":"Tsang","sequence":"additional","affiliation":[{"name":"Department of Renal Medicine Monash University Eastern Health Clinical School  Victoria Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Schembri","sequence":"additional","affiliation":[{"name":"Eastern Health Clinical School Monash University  Victoria Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence\u00a0P.","family":"McMahon","sequence":"additional","affiliation":[{"name":"Department of Renal Medicine Monash University Eastern Health Clinical School  Victoria Australia"},{"name":"Department of Renal Medicine Eastern Health  Victoria Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2025,6,4]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1093\/ageing\/afy169"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clnu.2008.04.007"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1038\/ejcn.2016.202"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.10261013"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2017.01.024"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12603-014-0505-5"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfw466"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcsm.13425"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clnu.2022.03.025"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ekir.2021.05.039"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11255-021-03085-1"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2009121293"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2003.00328.x"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0706130"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2011.826"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfp191"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI46122"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/nep.12333"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI200419081"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jamda.2019.12.012"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-020-02219-4"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchromb.2011.06.014"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.105.2.949"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1002\/mrd.1080390114"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-020-01831-8"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/17.7.1266"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/81.1.79"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2001-2-3-reviews3005"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0177(199804)211:4<362::AID-AJA7>3.0.CO;2-F"},{"key":"e_1_2_6_31_1","doi-asserted-by":"publisher","DOI":"10.1177\/002215540004800805"},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-4652(199912)181:3<499::AID-JCP14>3.0.CO;2-1"},{"issue":"85","key":"e_1_2_6_33_1","article-title":"Myogenic\u2010Specific Ablation of Fgfr1 Impairs FGF2\u2010Mediated Proliferation of Satellite Cells at the Myofiber Niche but Does Not Abolish the Capacity for Muscle Regeneration","volume":"7","author":"Yablonka\u2010Reuveni Z.","year":"2015","journal-title":"Frontiers in Aging Neuroscience"},{"key":"e_1_2_6_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.krcp.2012.04.435"},{"key":"e_1_2_6_35_1","doi-asserted-by":"publisher","DOI":"10.14336\/AD.2017.1214"},{"key":"e_1_2_6_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2016.02.009"},{"key":"e_1_2_6_37_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.00343.2017"},{"key":"e_1_2_6_38_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.00540.2019"}],"container-title":["Journal of Cachexia, Sarcopenia and Muscle"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jcsm.13848","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T10:24:05Z","timestamp":1750847045000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/jcsm.13848"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["10.1002\/jcsm.13848"],"URL":"https:\/\/doi.org\/10.1002\/jcsm.13848","archive":["Portico"],"relation":{},"ISSN":["2190-5991","2190-6009"],"issn-type":[{"value":"2190-5991","type":"print"},{"value":"2190-6009","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"2024-07-18","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-05-04","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-06-04","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e13848"}}